ADIPOQ and Impaired glucose tolerance: As we focused to the development of metabolic syndrome in this study, we were not able to exclude the possibility that CRP and HMW-adiponectin may be useful to predict each component of metabolic syndrome such as impaired glucose tolerance and dyslipidemia.